Prof. Shomron Ben-Horin M.D.
Co-founder of Evinature. Co-founder & Clinical Expert. Chief of the Gastroenterology Department & Director of the Gastro-Immunology Research Laboratory at Sheba Medical Center, one of Newsweek’s 10 best hospitals in the world.
Shomron Ben-Horin received his MD from the Hadassah School of Medicine of the Hebrew University of Jerusalem, before completing his gastroenterology training at Sheba Medical Center in Tel Aviv. He went on to conduct research at the Presbyterian Columbia University Hospital, New York, and spent a year in China as a visiting professor at the Sun Yat-sen University Hospital.
Currently a professor of Medicine at Tel Aviv University, Shomron has been the President of the Israel IBD Society, a member of the Scientific Committee of the European Crohn’s & Colitis Organization (ECCO), and an Associate Editor of the Journal of Crohn & Colitis. He is currently a member of the prestigious International Organization of IBD (IOIBD), and a member of the Editorial Board of leading journals, Gut, JCC and APT.
He has authored over 200 peer-reviewed articles and served as principal investigator and sub-investigator in over 20 clinical trials with a focus on drug mechanisms, therapeutic drug monitoring, immunogenicity of biologics, response to biologic antibody drugs in IBD, and opportunistic infections in IBD.
Shomron has been invited to lecture at numerous IBD congress and research meetings around the world, serves as a consultant to several biotech and biopharma companies, and was involved in the initiation of the CONFER project by the European Crohn’s & Colitis Organization. He is also Director of IBD Passport, a web-based global support program for traveling IBD patients.
In 2011, he teamed up with integrative expert Nir Salomon to lead a four-year international placebo-controlled trial testing an innovative gut-directed formulation of curcumin on UC patients. The results clearly affirmed curcumin’s efficacy in inducing clinical and endoscopic remission, and sparked the founding of Evinature in the hopes of providing safe, natural and clinically proven treatments to patients around the world.
Stay informed with the latest trials, treatments & fresh arrivals: